Represented Genenta Science S.p.A. in a foreign company U.S. IPO

In addition to handling all aspects of corporate matters for Genenta’s IPO, Loeb’s FDA team provided comprehensive regulatory advice and counsel on the IPO, including coordinating cross-border EU regulatory issues. Loeb’s Patent Litigation team managed IP diligence, drafted and negotiated the IP provisions of the Registration Statement.